Latest Operating Expenses News

GQG Partners delivered robust full-year 2024 results, marked by a 26.9% increase in funds under management and nearly 47% growth in net revenue, underpinned by strong investment performance and strategic initiatives including Private Capital Solutions and a new Abu Dhabi office.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.

Regal Asian Investments Limited has reported a significant half-year loss of $23.6 million, reversing last year’s profit, while announcing an increased fully franked interim dividend of 6.0 cents per share and expanding its on-market share buy-back program.

ASX Limited delivered a robust first half in 2025 with record operating revenue and a 10% rise in underlying NPAT, underscoring its strategic focus on technology modernisation and disciplined cost management.

Temple & Webster Group Ltd delivered a robust half-year performance with revenues climbing 24% to $313.7 million and profit after tax more than doubling to $9 million, underpinned by strategic growth initiatives and operational efficiencies.

ASX Limited reported a solid half-year performance for 1H25, with operating revenue up 5.9% to $541.9 million and an interim dividend increase to 111.2 cents per share. The company continues to invest heavily in technology upgrades while navigating ongoing regulatory scrutiny.

Sandon Capital Investments Limited reported a robust half-year performance with double-digit growth in revenue and profit, alongside a strategic shift to quarterly dividend payments starting March 2025.

ASB reported a modest 1% increase in cash net profit after tax for the half-year ending December 2024, underpinned by rising lending volumes and strategic investments in housing and fraud prevention amid New Zealand's gradual economic recovery.